Details of the Drug Reposition

General Information of This Drug (ID: DMB1N6P)

• Drug Name: Impoyz (DMB1N6P)
• Synonyms: Clobetasol propionate; CLOBETASOL PROPIONATE; 25122-46-7; Clobetasol 17-propionate; Clobex; Temovate; Dermovate; Embeline; Embeline E; Clobesol; Cormax; Olux; Temovate E; Olux-E; clobetasol 17-propanoate; GR 2/925; C25H32ClFO5; MLS000028708; Clobestasol propionate; Clobetasol propionate [USAN:JAN]; CGP 9555; CCI 4725; EINECS 246-634-3; 21-Chloro-9-fluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate; UNII-779619577M; [(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12

Information on Drug Reposition of This Drug

1 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Scalp dermatosis	DISN50RG	N.A.	Approved	[1]

2 Discontinued in Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Seborrhoeic dermatitis	DISNWVJU	EA81	Discontinued in Phase 3	[2]
Contact dermatitis	DISQ3AU0	EK0Z	Discontinued in Phase 3	[3]

2 Discontinued in Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Dermatitis	DISY5SZC	EA80-EA89	Discontinued in Phase 2	[4]
Plaque psoriasis	DISQX1LF	EA90.0	Discontinued in Phase 2	[5]

References

• [1] Post-traumatic erosive dermatosis of the scalp: A?hypergranulated variant. Australas J Dermatol. 2019 Nov;60(4):e322-e326.
• [2] ClinicalTrials.gov (NCT00574275) Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer
• [3] A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)
• [4] ClinicalTrials.gov (NCT01652014) Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies
• [5] Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia